Press release
March 4, 2026
Boundless Bio to Participate in the Leerink Global Healthcare Conference
Boundless Bio, Inc. (BOLD)
SAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that Zachary